Navigation Links
Rochester Medical Announces New Opportunity in the United Kingdom
Date:9/21/2009

STEWARTVILLE, Minn., Sept. 21 /PRNewswire-FirstCall/ -- Rochester Medical Corporation (Nasdaq: ROCM) today announced that the Company's FemSoft(R) Insert has been approved for inclusion in Part IX of the UK Drug Tariff as a prescription product which is reimbursable.

There are no other products listed in the Drug Tariff specifically for managing female stress urinary incontinence, and the Company believes that for many women this will be a very welcome addition that offers a discreet, non-surgical, odor-free, secure, and safe alternative to absorbents.

FemSoft(R) Inserts are particularly effective in situations where leakage occurs during certain physical activities such as exercise, coughing, laughing, or sneezing.

Hugh McLeod, General Manager of the U.K. business commented that this represents a significant opportunity for Rochester Medical and will enhance the Company's position as the leading worldwide innovator and marketer of silicone continence care devices.

He noted that the FemSoft(R) Insert product line fits perfectly alongside Rochester Medical's current portfolio of catheters for intermittent self-catheterization and will be marketed through the same customer base of Urology Nurse Specialists and Continence Nurse Specialists.

Commenting on the news, Anthony J. Conway Rochester Medical CEO and President said, "This is excellent news for women in the United Kingdom and also great news for Rochester Medical. We believe the FemSoft(R) Insert provides an elegant non-surgical, comfortable, and dry alternative to absorbents. Earlier this year we announced that U.S. Medicare has given preliminary reimbursement approval to the FemSoft Insert, and we expect final confirmation in the near future. In both the U.K. and U.S. we expect implementation of the reimbursement to begin in January 2010, and we are making sales and marketing preparations accordingly."

About Rochester Medical

Rochester Medical is the world's leading manufacturer of all-silicone catheters for urological and continence care applications. Our advanced line of latex-free products features male external catheters, intermittent catheters, Foley catheters and urethral inserts as well as latex-free accessories.

More information about Rochester Medical is available on its website at http://www.rocm.com.

Forward-Looking Statement

This press release contains "forward-looking statements" that are based on currently available information, operating plans and management's expectations about future events and trends. They inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in such forward-looking statements, including the uncertainty of estimated revenues and profits, the uncertainty of current domestic and international economic conditions that could adversely affect the level of demand for the Company's products and increased volatility in foreign exchange rates, the uncertainty of market acceptance of new product introductions, the uncertainty of gaining new strategic relationships or locating and capitalizing on strategic opportunities, the uncertainty of timing of private label sales revenues (particularly international customers), FDA and other regulatory review and response times, and other risk factors listed from time to time in the Company's SEC reports and filings, including, without limitation, the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended September 30, 2008 and subsequent reports on Forms 10-Q and 8-K. Readers are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

    Contact: Anthony J. Conway
    President and Chief Executive Officer
    Rochester Medical Corporation
    Phone: (507) 533-9600


'/>"/>
SOURCE Rochester Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rochester Medical Launches StrataSI(TM) & StrataNF(TM) Next Generation Foley Catheters
2. Rochester Medical Reports Third Quarter Results
3. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
4. Purple Communications Dream Bigger Initiative Honors Rochester Physician and Deaf Community Trailblazer
5. Rochester Medical Corporation Set to Join Russell 3000 Index
6. Rochester Medical Reports Second Quarter Results
7. Rochester Medical Announces Second Quarter 2009 Earnings Conference Call April 30, 2009
8. Rochester Medical Renews Share Repurchase Activity
9. University of Rochester Launches iTraining for Emergency Responders
10. Rochester Medical Reports First Quarter Results
11. Rochester study raises new questions about controversial plastics chemical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... ... Surgery Education and Anzu®, developers of the AnzuMedical™ Knowledge Sharing and Collaboration ... Collaborative Residency Network. The platform is scheduled to launch in July 2016 and ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... has been named a Top Doc in Physical Medicine and Rehabilitation by Philadelphia ... Castle Connolly Medical, Ltd. by randomly surveying physicians and medical leadership across the ...
(Date:4/28/2016)... ... 2016 , ... Starting today, households across the United States ... Prescription Assistance Program. They are customized to reflect the specific health needs of ... ready-to-use, state-themed card and, in the near future, material that highlights savings on ...
(Date:4/28/2016)... ... , ... North Hollywood dentist , Dr. Hamid Reza, now offers emergency ... comes to dental accidents or critical dental problems. These issues can threaten a person's ... knocked-out teeth, chipped teeth, and many other issues can lead to emergency situations, and ...
(Date:4/28/2016)... California (PRWEB) , ... April 28, 2016 , ... For many, a diet is only ... crave it if it does not look good. In addition, an individual cannot deny the ... well. , The team, therefore, has worked to create a product range that could ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)... --   , Total Sales ... Sales  Clinical sales grow 16% year-over-year  , ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... quarter ended March 31, 2016 and provided an update ... strategy. First Quarter 2016 Revenue Results by ...
Breaking Medicine Technology: